Detalhe da pesquisa
1.
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Diabetes Obes Metab
; 25(2): 545-555, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263928
2.
Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice.
Diabetes Educ
; 45(1_suppl): 3S-20S, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30541402
3.
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists.
J Fam Pract
; 66(10 Suppl): S12-S16, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28991932
4.
AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.
Diabetes Care
; 37(8): 2132-40, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24742662
5.
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Nat Clin Pract Endocrinol Metab
; 3(5): E1; discussion E2, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17452962
6.
Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
Diabetes Care
; 37(12): e263-4, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414399